Cybergenetics Awarded Contract To Identify World Trade Center Victim Remains Using TrueAllele(R) Technology; Advanced TrueAllele(R) SuperComputer To Help Identify WTC Victims

Published: Sep 08, 2006

PITTSBURGH--(BUSINESS WIRE)--Sept. 8, 2006--Cybergenetics has been awarded a contract by New York City's Office of the Chief Medical Examiner (OCME) to apply its unique TrueAllele(R) technology for identifying World Trade Center (WTC) remains. Cybergenetics is the leading innovator of automated forensic DNA interpretation technology.

Back to news